Literature DB >> 8237999

Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-globin variant, observed in combination with the -(alpha)20.5 Kb alpha-thal-1 deletion in two Turkish patients.

M A Cürük1, A J Dimovski, E Baysal, L H Gu, F Kutlar, T P Molchanova, B B Webber, C Altay, A Gürgey, T H Huisman.   

Abstract

We have identified a severely unstable hemoglobin variant through sequencing of amplified DNA involving the alpha 1-globin gene; the mutation is located in codon 59 (CCG CAG) and results in a Gly-->Asp replacement. This amino acid substitution concerns a glycine residue at an internal position in the E helix, which is in close contact with a glycine residue of the B helix; introduction of the larger and charged aspartic acid residue greatly affects the stability of the molecule. This variant was present in association with a common alpha-thalassemia-1 deletion [-(alpha)20.5 kb] in two adults and caused a severe type of Hb H disease with anemia, low levels of Hb A2, increased zeta chain, and Hb Bart's. In vitro chain synthesis in reticulocytes showed a high specific activity of the variant alpha chain. Only a minute quantity of Hb H was present but instead about 10% of Hb Bart's was observed. The increased synthesis of gamma chains was likely due to specific characteristics of a chromosome with haplotype #3, which was present in both patients. The same family was studied 18 years ago; the improved methodology presently available has led to a corrected diagnosis for these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8237999     DOI: 10.1002/ajh.2830440410

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Α case of late diagnosis of compound heterozygosity for Hb Adana (HBA2:c.179G>A) in trans to an α+- thalassemia deletion: guilty or innocent.

Authors:  A Tampaki; S Theodoridou; Ch Apostolou; E E Delaki; E Vlachaki
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

2.  Molecular spectrum of α-globin gene mutations in the Aegean region of Turkey: first observation of three α-globin gene mutations in the Turkish population.

Authors:  Hüseyin Onay; Ayça Aykut; Emin Karaca; Asude Durmaz; Aslı Ece Solmaz; Özgür Çoğulu; Yeşim Aydınok; Canan Vergin; Ferda Özkınay
Journal:  Int J Hematol       Date:  2015-05-05       Impact factor: 2.490

Review 3.  Alpha-thalassaemia.

Authors:  Cornelis L Harteveld; Douglas R Higgs
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

4.  Hydrops fetalis associated with homozygosity for Hb Adana [alpha59(E8)Gly-->Asp (alpha2)].

Authors:  Ita M Nainggolan; Alida Harahap; Iswari Setianingsih
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

Review 5.  Genetic epidemiology of hemoglobinopathies among Iraqi Kurds.

Authors:  Nasir Al-Allawi; Sarah Al Allawi; Sana D Jalal
Journal:  J Community Genet       Date:  2020-11-22

6.  Distribution of alpha thalassaemia gene variants in diverse ethnic populations in malaysia: data from the institute for medical research.

Authors:  Rahimah Ahmad; Mohamed Saleem; Nisha Sabrina Aloysious; Punithawathy Yelumalai; Nurul Mohamed; Syahzuwan Hassan
Journal:  Int J Mol Sci       Date:  2013-09-10       Impact factor: 5.923

7.  Severe α-thalassemia intermedia due to a compound heterozygosity for the highly unstable Hb Adana (HBA2: c.179G>A) and a novel codon 24 (HBA2: c.75T>A) mutation.

Authors:  Dewi Megawati; Ita M Nainggolan; Maria Swastika; Susi Susanah; Johanes C Mose; Alida R Harahap; Iswari Setianingsih
Journal:  Hemoglobin       Date:  2013-12-18       Impact factor: 0.849

8.  Hemoglobin H Disease in Turkey: Experience from Eight Centers.

Authors:  Selma Ünal; Gönül Oktay; Can Acıpayam; Gül İlhan; Edip Gali; Tiraje Celkan; Ali Bay; Barış Malbora; Nejat Akar; Yeşim Oymak; Tayfur Toptaş
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

9.  DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia.

Authors:  Jin Ai Mary Anne Tan; Siew Leng Kho; Chin Fang Ngim; Kek Heng Chua; Ai Sim Goh; Seoh Leng Yeoh; Elizabeth George
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

10.  Interaction of Hb adana (HBA2: c.179G>A) with deletional and nondeletional α(+)-thalassemia mutations: diverse hematological and clinical features.

Authors:  Ita M Nainggolan; Alida Harahap; Debby D Ambarwati; Rosalina V Liliani; Dewi Megawati; Maria Swastika; Iswari Setianingsih
Journal:  Hemoglobin       Date:  2013-04-25       Impact factor: 0.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.